Seite - 16 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Bild der Seite - 16 -
Text der Seite - 16 -
Condeetal. Biofunctionalizationandsurfacechemistryof inorganicnanoparticles
propertiesof thebiological cargowithoutany indicationofnon-
specificbindingorparticleaggregation(Wangetal., 2005).
The stability conferred by peptide ligands usually depends
on their length, hydrophobicity, and charge and in some cases
resulted in further improved stability. Actually, Levy et al.
designed a pentapeptide ligand, CALNN,which converts citrate
stabilizedAuNPsintoextremelystable,water-solubleAuNPswith
some chemical properties analogous to those of proteins. These
peptide-capped AuNPs can be freeze-dried and stored as pow-
ders that canbe subsequently redissolved toyield stable aqueous
dispersions(Levyetal., 2004).
Biofunctional peptide sequences include “membrane translo-
cation signals” like theHIV-TATpeptide sequence (de la Fuente
andBerry, 2005; Berry et al., 2007; Conde et al., 2012a), which
is capable of transporting nanoscale materials across cellular
membranes and “nuclear locating signals” that could be used
for further intracellular targeting (Nativo et al., 2008;Chithrani,
2010). In fact, de la Fuente et al. developed AuNPs functional-
izedwithHIV-Tatpeptideused toachievecytoplasmandthecell
nucleus. One of the major drawbacks of these cell penetrating
peptides is that theyarenotcell specificandthat theycanremain
entrappedinendosomes(GumpandDowdy,2007).Toovercome
these limitations, fusogenicpeptides that are able to escape from
endosomes or homing peptides capable of reaching specific tis-
suesor cellshavebeendeveloped(Li et al., 2004;Ruoslahti et al.,
2010).
QDslabeledwiththese typesofpeptideshavebeenextensively
prepared using various strategies (Chen and Gerion, 2004; Cai
andChen,2008;Curnisetal.,2008).Forexample,Akermanetal.
show that ZnS-capped CdSe QDs coated with a lung-targeting
peptide accumulate in the lungs ofmice after intravenous injec-
tion,whereas twootherpeptides specificallydirectQDs toblood
or lymphatic vessels in tumors (Akerman et al., 2002). Curnis
etal. also foundthatacyclicCisoDGRCpeptidecoupled toQDs
couldbindalphavbeta3integrinandco-localizewithseveralanti-
bodies in human renal cell carcinoma tissue sections, indicating
that this peptide could efficiently recognize endothelial cells of
angiogenic vessels (Curnis et al., 2008).Cai et al. alsouseda thi-
olatedarginine-glycine-aspartic acid(RGD)peptide toconjugate
to theQDsandappliedtheQDspeptidebioconjugates for tumor
vasculature targeted imaging (Cai andChen, 2008).However, if
crossing thevascularwall is needed, theseRGDpeptidesneed to
beimproved.TheRuoshlatigroupreportedacyclicpeptideiRGD
thatcancombine the tumor-homingRGDsequencewitha tissue
penetrationmotif (Sugahara et al., 2009).Therefore, thehoming
sequencedirects thepeptide to the tumorvascular endothelium,
while the tissue penetration motif, once activated by a pro-
tease,bindstoadifferentreceptor(neuropilin-1),whichmediates
extravasationandtissuepenetration.Asaproofofconcept, iRGD
peptide-linked ironoxidenanowormscouldbedetectedbyMRI
throughout a tumor once injected in vivo tomice. Recently, the
same group combined twodifferent peptideswith themagnetic
nanoworms to image and treat mice with glioblastoma, one of
the most difficult tumors to treat (Agemy et al., 2011). While
theCGKRGpeptide targets theNPs to tumor vascular cells and
intotheirmitochondria, theotherpeptideactsasapro-apoptotic
drug. By co-injecting theseNPswith iRGD,most of the tumors wereeradicatedortheirdevelopmentdelayedintwoglioblastoma
mousemodels.
Despite the extraordinary rapiddevelopment in strategies for
nanoparticle conjugationwithpeptides, relatively little is known
aboutNPbehavior in the immune system,which is responsible
for maintaining body integrity and preventing external inva-
sion. Bastus et al. described the interaction between murine
bonemarrowmacrophages and gold nanoparticle peptide con-
jugates. In the presence of conjugates, macrophage prolifera-
tionwas stoppedandpro-inflammatorycytokineswere induced.
Furthermore,macrophageactivationbyAuNPsconjugatedtodif-
ferent peptides appeared to be rather independent of peptide
length and polarity, but dependent on peptide pattern at the
nanoparticle surface(Bastusetal., 2009).
Proteins/antibodies
In Bionanotechnology, specific functions of proteins such as
antibody–antigen detectionmay also be very useful. Antibodies
(Abs)orimmunoglobulinsareagroupofproteinsthathaveavery
similar structurewith fourchainsassembled inaYshaped form,
containing two identical domains for antigen recognition (Fab
fragment), andtwoidenticaldomainswitheffector functions(Fc
fragment).ThemainadvantageofAbsor their fragments is that
theantigen-bindingregion ishighly specificanddifferentamong
Abs (Arrueboet al., 2009).Therefore, different specificity canbe
obtained using distinct Abs.However, attachment of Abs to the
surface of NPs can impair this function if the antigen binding
sites are stericallyblockeduponconjugation.For this reason, the
Abs orientation is extremely important to produce effective and
bioactiveantibody-nanoparticles.
In fact,de laFuenteetal. recentlydemonstratedthat thecom-
bination of a goodAb orientation alongwith the property of a
goldnanoprism togenerateheatwhen illuminatedwith the cor-
rectwavelengthenablevisualdetectionofcarcinoembryonicanti-
gen(CEA)byplasmonic-driventhermalsensingwithsensitivities
upto theattomolar range inserumsamples (Poloetal., 2013).
Immunoassays use the specificity and sensitivity of the
antibody-antigen interaction inorder to detect andquantify the
amountof a specificanalytepresent ina sample.Effective conju-
gatedantibodiescanbeusedtoconstitute thedesired functional-
ityof thenanocarrier itself for immunoassays (Hanet al., 2003).
Actually, Putman et al. described the use of immunogold labels
as cell-surface markers of human lymphocytes in atomic force
microscopy.TheAFMimagesrevealthecolloidalgoldparticleson
thecell surface,withandwithout silver enhancement. Individual
immunogold particles are clearly resolved from the cell surface
thusdetermining the locationofantigens(Putmanetal., 1993).
Ni et al. described an immunoassay readout method based
on surface enhanced Raman scattering (SERS). The method
exploits the SERS-derived signal from reporter molecules that
are co-immobilized with biospecific species on gold colloids.
This concept is demonstrated in a dual analyte sandwich assay,
in which two different antibodies covalently bound to a solid
substratespecificallycapturetwodifferentantigensfromanaque-
ous sample. The captured antigens in turn bind selectively to
theircorrespondingdetectionantibodies.Thedetectionantibod-
iesareconjugatedwithgoldcolloidsthatarelabeledwithdifferent
www.frontiersin.org July2014 |Volume2 |Article48 | 16
Cancer Nanotheranostics
What Have We Learnd So Far?
- Titel
- Cancer Nanotheranostics
- Untertitel
- What Have We Learnd So Far?
- Autoren
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Herausgeber
- Frontiers in Chemistry
- Datum
- 2016
- Sprache
- englisch
- Lizenz
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Abmessungen
- 21.0 x 27.7 cm
- Seiten
- 132
- Schlagwörter
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Kategorien
- Naturwissenschaften Chemie